Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Drug-Related Side Effects and Adverse Reactions 2 Cardiovascular Diseases 2 Cardiotoxicity 2 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

Blood Specimen Collection 7 Drug Therapy 6 Surveys and Questionnaires 5 Radiotherapy 5 Radiosurgery 5 Docetaxel 5 Therapeutics 4 Specimen Handling 4 Immunotherapy 4 Hepatectomy 4 exemestane 3 enzalutamide 3 apalutamide 3 Trastuzumab 3 Hematologic Tests 3 Data Collection 3 Biopsy 3 Biological Assay 3 Anastrozole 3 Abiraterone Acetate 3 trastuzumab deruxtecan 2 palbociclib 2 darolutamide 2 abiraterone 2 abemaciclib 2 Wearable Electronic Devices 2 Triptorelin Pamoate 2 Tamoxifen 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasm Metastasis × Social Determinants of Health × Clear all

NCT06081517 2025-06-13

EDPO

Indiana University

10,600 enrolled

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡